• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Biologic behavior of thin malignant melanomas with regressive changes.

作者信息

Paladugu R R, Yonemoto R H

出版信息

Arch Surg. 1983 Jan;118(1):41-4. doi: 10.1001/archsurg.1983.01390010031008.

DOI:10.1001/archsurg.1983.01390010031008
PMID:6848075
Abstract

Thin cutaneous malignant melanomas are defined as lesions measuring less than 0.76 mm in maximal thickness. Eight of the 36 thin lesions that we studied metastasized within two to 120 months. Of the 11 lesions with regressive features, five (45.5%) metastasized. Of 25 lesions without regression, only three (12%) metastasized. Thin melanomas with regressive changes need to be reported as a separate category because of their propensity to metastasize. Conventional prognostic guidelines for treatment of thin melanomas are not applicable to this type of lesion. Clinicians need to be cognizant that regressive changes are serious warning signals when they occur in thin melanomas.

摘要

相似文献

1
Biologic behavior of thin malignant melanomas with regressive changes.
Arch Surg. 1983 Jan;118(1):41-4. doi: 10.1001/archsurg.1983.01390010031008.
2
Metastases of thin melanomas.薄型黑色素瘤的转移
Cancer. 1983 Feb 1;51(3):553-6. doi: 10.1002/1097-0142(19830201)51:3<553::aid-cncr2820510332>3.0.co;2-t.
3
Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance.薄恶性黑色素瘤的消退。显微镜诊断及预后意义。
Arch Dermatol. 1985 Sep;121(9):1127-31.
4
Prognostic factors in thin cutaneous malignant melanoma.薄型皮肤恶性黑色素瘤的预后因素
Cancer. 1994 May 1;73(9):2324-32. doi: 10.1002/1097-0142(19940501)73:9<2324::aid-cncr2820730914>3.0.co;2-5.
5
The regressing thin malignant melanoma: a distinctive lesion with metastatic potential.消退性薄恶性黑色素瘤:一种具有转移潜能的独特病变。
Cancer. 1978 Nov;42(5):2282-92. doi: 10.1002/1097-0142(197811)42:5<2282::aid-cncr2820420528>3.0.co;2-v.
6
Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group.伴有转移的薄型(<1.0mm)皮肤黑色素瘤中与转移潜能相关的组织学特征鉴定。一项代表欧洲癌症研究与治疗组织黑色素瘤小组开展的研究。
J Pathol. 2002 Jun;197(2):188-93. doi: 10.1002/path.1093.
7
Problems in the interpretation of apparent "radial growth phase" malignant melanomas that metastasize.转移性明显处于“径向生长阶段”的恶性黑色素瘤的解读问题。
J Cutan Pathol. 2002 Aug;29(7):407-14. doi: 10.1034/j.1600-0560.2002.290704.x.
8
Microvascular lymphatic density analysis in cutaneous regressive and nonregressive superficial spreading melanomas using the lymphatic marker D2-40.使用淋巴管标志物D2-40对皮肤消退型和非消退型浅表扩散性黑色素瘤进行微血管淋巴管密度分析。
Am J Dermatopathol. 2011 Oct;33(7):669-74. doi: 10.1097/DAD.0b013e31820d9bf3.
9
Cutaneous melanomas that defy conventional prognostic indicators.对传统预后指标无反应的皮肤黑色素瘤。
Semin Oncol. 1996 Dec;23(6):709-13.
10
Thin malignant melanomas with regression and metastases.伴有消退和转移的薄型恶性黑色素瘤。
Arch Dermatol. 1987 Oct;123(10):1326-30.

引用本文的文献

1
Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance.原发性皮肤黑色素瘤的消退:病因发病机制及临床意义。
Lab Invest. 2017 Jun;97(6):657-668. doi: 10.1038/labinvest.2017.8. Epub 2017 Feb 27.
2
Variations in the expression of TIMP1, TIMP2 and TIMP3 in cutaneous melanoma with regression and their possible function as prognostic predictors.伴有消退的皮肤黑色素瘤中TIMP1、TIMP2和TIMP3表达的变化及其作为预后预测指标的可能作用。
Oncol Lett. 2016 May;11(5):3354-3360. doi: 10.3892/ol.2016.4391. Epub 2016 Mar 29.
3
Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma.
前哨淋巴结活检的结果及薄型恶性黑色素瘤消退的预后意义。
Melanoma Res. 2012 Aug;22(4):302-9. doi: 10.1097/CMR.0b013e328353e673.
4
Melanoma peptide vaccines: from preclinical background to clinical trials.黑色素瘤肽疫苗:从临床前背景到临床试验
Curr Oncol Rep. 2000 Jan;2(1):38-47. doi: 10.1007/s11912-000-0009-9.
5
Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression.转化生长因子-β2在恶性黑色素瘤中的表达与肿瘤浸润深度相关。对肿瘤进展的影响。
Am J Pathol. 1994 Jul;145(1):97-104.
6
Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis.消退性薄皮肤恶性黑色素瘤(≤1.0毫米)与血管生成有关。
Am J Pathol. 1993 Jul;143(1):99-104.
7
Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells.人类黑色素瘤/非黑色素瘤皮肤癌的自发消退:与浸润性CD4 + T细胞的关联。
World J Surg. 1995 May-Jun;19(3):352-8. doi: 10.1007/BF00299157.
8
Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas.血管化程度作为薄型(<0.76毫米)恶性黑色素瘤的预后指标
Am J Pathol. 1994 Sep;145(3):510-4.
9
Clinical features of superficial spreading melanomas with zones of regression.伴有消退区的浅表扩散型黑色素瘤的临床特征。
J Cancer Res Clin Oncol. 1984;107(3):225-8. doi: 10.1007/BF01032612.
10
Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression.四肢的薄型(小于或等于1毫米)黑色素瘤是生物学上预后良好的病变,不受消退影响。
Ann Surg. 1985 Apr;201(4):499-504. doi: 10.1097/00000658-198504000-00016.